Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Alterna Therapeutics

Alterna Therapeutics
2015 FOUNDED
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
2 INVESTORS
Description

Developer of therapeutics intended to treat diabetes and obesity. The company's therapeutics target fat tissues that are known to limit inflammation and SHIP enzyme for the treatment of obesity, enabling patients to control obesity without any side effects.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Other Healthcare Services
Primary Office
  • 201 West Main Street
  • Suite 300, PMB 317
  • Durham, NC 27701
  • United States

+1 (919) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Alterna Therapeutics’s full profile, request a free trial.

Alterna Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 02-Mar-2016 Completed Startup
1. Seed Round 15-Nov-2015 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Alterna Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
JLABS Accelerator/Incubator Minority 000 0000 000000 0
Golden Pine Ventures Venture Capital Minority 000 0000 000000 0

Alterna Therapeutics Executive Team (1)

Name Title Board
Seat
Contact
Info
William Kerr Ph.D Chief Scientific Officer